GENENTA SCIENCE(SP.ADR)/1 (K5F) - Total Assets

Latest as of December 2025: €31.89 Million EUR ≈ $37.28 Million USD

Based on the latest financial reports, GENENTA SCIENCE(SP.ADR)/1 (K5F) holds total assets worth €31.89 Million EUR (≈ $37.28 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See GENENTA SCIENCE(SP.ADR)/1 book value and equity for net asset value and shareholders' equity analysis.

GENENTA SCIENCE(SP.ADR)/1 - Total Assets Trend (2021–2025)

This chart illustrates how GENENTA SCIENCE(SP.ADR)/1's total assets have evolved over time, based on quarterly financial data.

GENENTA SCIENCE(SP.ADR)/1 - Asset Composition Analysis

Current Asset Composition (December 2025)

GENENTA SCIENCE(SP.ADR)/1's total assets of €31.89 Million consist of 94.0% current assets and 6.0% non-current assets.

Asset Category	Amount (EUR)	% of Total Assets
Cash & Equivalents	€0.00	17.3%
Accounts Receivable	€0.00	0.0%
Inventory	€0.00	0.0%
Property, Plant & Equipment	€0.00	0.0%
Intangible Assets	€0.00	0.0%
Goodwill	€0.00	0.0%

Asset Composition Trend (2021–2025)

This chart illustrates how GENENTA SCIENCE(SP.ADR)/1's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see GENENTA SCIENCE(SP.ADR)/1 stock valuation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: GENENTA SCIENCE(SP.ADR)/1's current assets represent 94.0% of total assets in 2025, a decrease from 96.8% in 2021.
Cash Position: Cash and equivalents constituted 17.3% of total assets in 2025, down from 93.0% in 2021.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.

GENENTA SCIENCE(SP.ADR)/1 Competitors by Total Assets

Key competitors of GENENTA SCIENCE(SP.ADR)/1 based on total assets are shown below.

Company	Country	Total Assets
Xizang Haisco Pharmaceutical Group Co Ltd SHE:002653	China	CN¥7.21 Billion
CSL Ltd AU:CSL	Australia	AU$39.54 Billion
Sk Biopharmaceuticals Co Ltd KO:326030	Korea	₩1.20 Trillion
Crispr Therapeutics AG NASDAQ:CRSP	USA	$2.73 Billion
Tubize-Fin BR:TUB	Belgium	€1.93 Billion
Ascendis Pharma AS F:A71	Germany	€2.00 Billion
NANOBIOTIX S.A. SP.ADR F:5NRA	Germany	€67.76 Million
Innovita Biological Technology Co. Ltd. A SHG:688253	China	CN¥2.23 Billion

GENENTA SCIENCE(SP.ADR)/1 - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	14.16	6.89	9.30
Quick Ratio	14.16	6.89	9.30
Cash Ratio	0.00	0.00	0.00
Working Capital	€27.86 Million	€12.37 Million	€16.57 Million

GENENTA SCIENCE(SP.ADR)/1 - Advanced Valuation Insights

This section examines the relationship between GENENTA SCIENCE(SP.ADR)/1's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	0.51
Latest Market Cap to Assets Ratio	0.45
Asset Growth Rate (YoY)	115.1%
Total Assets	€31.89 Million
Market Capitalization	$14.25 Million USD

Valuation Analysis

Below Book Valuation: The market values GENENTA SCIENCE(SP.ADR)/1's assets below their book value (0.45x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: GENENTA SCIENCE(SP.ADR)/1's assets grew by 115.1% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for GENENTA SCIENCE(SP.ADR)/1 (2021–2025)

The table below shows the annual total assets of GENENTA SCIENCE(SP.ADR)/1 from 2021 to 2025.

Year	Total Assets	Change
2025-12-31	€31.89 Million ≈ $37.28 Million	+115.12%
2024-12-31	€14.82 Million ≈ $17.33 Million	-33.66%
2023-12-31	€22.35 Million ≈ $26.13 Million	-33.17%
2022-12-31	€33.44 Million ≈ $39.09 Million	-16.46%
2021-12-31	€40.03 Million ≈ $46.80 Million	--

About GENENTA SCIENCE(SP.ADR)/1

F:K5F Germany Biotechnology

Market Cap

$14.25 Million

€12.18 Million EUR

Market Cap Rank

#26153 Global

#2263 in Germany

Share Price

€0.52

Change (1 day)

+0.00%

52-Week Range

€0.47 - €3.68

All Time High

€10.50